Literature DB >> 3049908

Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture.

K Koike1, T Nakahata, M Takagi, T Kobayashi, A Ishiguro, K Tsuji, K Naganuma, A Okano, Y Akiyama, T Akabane.   

Abstract

We investigated the effects of B cell stimulatory factor 2/interleukin 6 (BSF-2/IL-6) on the development of murine hemopoietic progenitors using serum-containing culture and serum-free culture. In serum-containing culture, BSF-2 mainly supported multipotential blast cell colonies from spleen cells of normal and 5-fluorouracil (5-FU)-treated mice. In serum-free culture, no colony growth was seen in the presence of BSF-2. Addition of BSF-2 to the serum-free culture containing IL-3 resulted in a significant increase in the number of colonies formed from multipotential progenitors in spleen cells and bone marrow cells of 5-FU-treated mice, whereas no effects were seen on the number of single or oligolineage colonies formed by the spleen cells of normal mice. These results suggested that BSF-2 and IL-3 act synergistically on the multipotential progenitors but not on the maturer progenitors. When BSF-2 was added to a culture containing low concentrations of IL-3 (1 U/ml, 4 U/ml), which had little effect on colony formation, the number of total colonies formed by the spleen cells and bone marrow cells of 5-FU-treated mice increased significantly. The combination of BSF-2 and 40 U/ml of IL-3 resulted in a significant enlargement of GMM colonies. Thus, BSF-2 appears to enhance the sensitivity of multipotential hemopoietic progenitors to IL-3.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049908      PMCID: PMC2189042          DOI: 10.1084/jem.168.3.879

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Declining sensitivity to interleukin 3 of murine multipotential hemopoietic progenitors during their development. Application to a culture system that favors blast cell colony formation.

Authors:  K Koike; J N Ihle; M Ogawa
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

2.  Macrophage colony formation supported by purified CSF-1 and/or interleukin 3 in serum-free culture: evidence for hierarchical difference in macrophage colony-forming cells.

Authors:  K Koike; E R Stanley; J N Ihle; M Ogawa
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

3.  Clonal assay of mouse mast cell colonies in methylcellulose culture.

Authors:  T Nakahata; S S Spicer; J R Cantey; M Ogawa
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

4.  Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell?

Authors:  G S Hodgson; T R Bradley
Journal:  Nature       Date:  1979-10-04       Impact factor: 49.962

5.  Synergism between hemopoietic growth factors (HGFs) detected by their effects on cells bearing receptors for a lineage specific HGF: assay of hemopoietin-1.

Authors:  S H Bartelmez; E R Stanley
Journal:  J Cell Physiol       Date:  1985-03       Impact factor: 6.384

6.  Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies.

Authors:  T Nakahata; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Clonal origin of murine hemopoietic colonies with apparent restriction to granuclocyte-macrophage-megakaryocyte (GMM) differentiation.

Authors:  T Nakahata; M Ogawa
Journal:  J Cell Physiol       Date:  1982-06       Impact factor: 6.384

8.  Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Authors:  K Ikebuchi; G G Wong; S C Clark; J N Ihle; Y Hirai; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  Proliferative kinetics and differentiation of murine blast cell colonies in culture: evidence for variable G0 periods and constant doubling rates of early pluripotent hemopoietic progenitors.

Authors:  T Suda; J Suda; M Ogawa
Journal:  J Cell Physiol       Date:  1983-12       Impact factor: 6.384

10.  Permissive role of interleukin 3 (IL-3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture.

Authors:  T Suda; J Suda; M Ogawa; J N Ihle
Journal:  J Cell Physiol       Date:  1985-08       Impact factor: 6.384

View more
  27 in total

1.  Ki-1 lymphoma with nodular involvement in liver and spleen: possible role of cytokines in systemic manifestation of fever and leukocytosis.

Authors:  Y Harada; S Yamada; S Murakami; S Mine; Y Momosaka; J Tsukada; I Morimoto; S Eto
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Hemopoietic functions of marrow-derived osteogenic cells.

Authors:  D Benayahu; M Horowitz; D Zipori; S Wientroub
Journal:  Calcif Tissue Int       Date:  1992-09       Impact factor: 4.333

3.  Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters.

Authors:  D M Nachbaur; M Herold; A Maneschg; H Huber
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

Review 4.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

Review 5.  Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.

Authors:  K Yoshizaki; N Nishimoto; M Mihara; T Kishimoto
Journal:  Springer Semin Immunopathol       Date:  1998

Review 6.  Role of interleukin-1 in hematopoiesis.

Authors:  M A Moore
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

7.  A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF.

Authors:  I Nishijima; T Nakahata; Y Hirabayashi; T Inoue; H Kurata; A Miyajima; N Hayashi; Y Iwakura; K Arai; T Yokota
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

Review 8.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

9.  Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture.

Authors:  G K Wollenberg; L E DeForge; G Bolgos; D G Remick
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

Review 10.  IL-6 cytokine family and signal transduction: a model of the cytokine system.

Authors:  M Hibi; K Nakajima; T Hirano
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.